*Bundesamt fuer Strahlenschutz (Germany); †Public Health England (United Kingdom); ‡Universitat Autonoma de Barcelona (Spain); §Institut de Radioprotection et de Sûreté Nucleaire (France); **Bundeswehr Institute of Radiobiology affiliated to the University of Ulm (Germany); ††Stockholm University (Sweden); ‡‡Radiation and Nuclear Safety Authority (Finland); §§Institute of Nuclear Chemistry and Technology (Poland); ***University of Ghent (Belgium).
Health Phys. 2014 Jun;106(6):764-71. doi: 10.1097/HP.0000000000000077.
Large scale radiological emergencies require high throughput techniques of biological dosimetry for population triage in order to identify individuals indicated for medical treatment. The dicentric assay is the "gold standard" technique for the performance of biological dosimetry, but it is very time consuming and needs well trained scorers. To increase the throughput of blood samples, semi-automation of dicentric scoring was investigated in the framework of the MULTIBIODOSE EU FP7 project, and dose effect curves were established in six biodosimetry laboratories. To validate these dose effect curves, blood samples from 33 healthy donors (>10 donors/scenario) were irradiated in vitro with ⁶⁰Co gamma rays simulating three different exposure scenarios: acute whole body, partial body, and protracted exposure, with three different doses for each scenario. All the blood samples were irradiated at Ghent University, Belgium, and then shipped blind coded to the participating laboratories. The blood samples were set up by each lab using their own standard protocols, and metaphase slides were prepared to validate the calibration curves established by semi-automatic dicentric scoring. In order to achieve this, 300 metaphases per sample were captured, and the doses were estimated using the newly formed dose effect curves. After acute uniform exposure, all laboratories were able to distinguish between 0 Gy, 0.5 Gy, 2.0, and 4.0 Gy (p < 0.001), and, in most cases, the dose estimates were within a range of ± 0.5 Gy of the given dose. After protracted exposure, all laboratories were able to distinguish between 1.0 Gy, 2.0 Gy, and 4.0 Gy (p < 0.001), and here also a large number of the dose estimates were within ± 0.5 Gy of the irradiation dose. After simulated partial body exposure, all laboratories were able to distinguish between 2.0 Gy, 4.0 Gy, and 6.0 Gy (p < 0.001). Overdispersion of the dicentric distribution enabled the detection of the partial body samples; however, this result was clearly dose-dependent. For partial body exposures, only a few dose estimates were in the range of ± 0.5 Gy of the given dose, but an improvement could be achieved with higher cell numbers. The new method of semi-automation of the dicentric assay was introduced successfully in a network of six laboratories. It is therefore concluded that this method can be used as a high-throughput screening tool in a large-scale radiation accident.
大规模放射事故需要高通量的生物剂量测定技术,以便对人群进行分类,以确定需要治疗的个体。双着丝粒分析是生物剂量测定的“金标准”技术,但它非常耗时,需要经过良好培训的评分者。为了增加血液样本的通量,在 MULTIBIODOSE EU FP7 项目的框架内研究了双着丝粒评分的半自动分析,并在六个生物剂量测定实验室中建立了剂量效应曲线。为了验证这些剂量效应曲线,用 ⁶⁰Co 伽马射线模拟三种不同的暴露情况(急性全身、局部和长期暴露),对 33 名(每个场景 >10 名供体)健康供体的血液样本进行了体外照射,每个场景的三种剂量。所有血液样本均在比利时根特大学进行照射,然后以盲码形式运送到参与实验室。每个实验室均按照自己的标准方案设置血液样本,并制备中期分裂相幻灯片,以验证半自动双着丝粒评分建立的校准曲线。为此,每个样本捕获了 300 个中期分裂相,并使用新形成的剂量效应曲线估计剂量。在急性均匀暴露后,所有实验室均能够区分 0 Gy、0.5 Gy、2.0 和 4.0 Gy(p < 0.001),并且在大多数情况下,剂量估计值在给定剂量的 ± 0.5 Gy 范围内。在长期暴露后,所有实验室均能够区分 1.0 Gy、2.0 Gy 和 4.0 Gy(p < 0.001),并且在此情况下,大量剂量估计值也在照射剂量的 ± 0.5 Gy 范围内。在模拟局部身体暴露后,所有实验室均能够区分 2.0 Gy、4.0 Gy 和 6.0 Gy(p < 0.001)。双着丝粒分布的离散度使得能够检测到局部身体样本;然而,这一结果显然是剂量依赖性的。对于局部身体暴露,只有少数剂量估计值在给定剂量的 ± 0.5 Gy 范围内,但可以通过增加细胞数量来提高。双着丝粒分析的半自动新方法已成功引入到六个实验室的网络中。因此可以得出结论,该方法可作为大规模辐射事故中的高通量筛选工具。